| 215380 Stock | | | KRW 1,648 72.00 4.19% |
CEO
Byeong Cheon is Chief Executive Officer, Director of WOOJUNG BIO since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 82 3 1888 9369 |
| Web | http://www.woojungbsc.co.kr |
WOOJUNG BIO Management Efficiency
The company has return on total asset
(ROA) of
(0.0566) % which means that it has lost $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(24.1357) %, meaning that it generated substantial loss on money invested by shareholders. WOOJUNG BIO's management efficiency ratios could be used to measure how well WOOJUNG BIO manages its routine affairs as well as how well it operates its assets and liabilities.
WOOJUNG BIO has accumulated 28.1
B in total debt with debt to equity ratio
(D/E) of 0.92, which is about average as compared to similar companies. WOOJUNG BIO has a current ratio of 1.63, which is within standard range for the sector. Debt can assist WOOJUNG BIO until it has trouble settling it off, either with new capital or with free cash flow. So, WOOJUNG BIO's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like WOOJUNG BIO sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for WOOJUNG to invest in growth at high rates of return. When we think about WOOJUNG BIO's use of debt, we should always consider it together with cash and equity.
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea. WOOJUNG BIO is traded on Korean Securities Dealers Automated Quotations in South Korea. WOOJUNG BIO (215380) is traded on KOSDAQ in Korea and employs 10 people.
Management Performance
WOOJUNG BIO Leadership Team
Elected by the shareholders, the WOOJUNG BIO's board of directors comprises two types of representatives: WOOJUNG BIO inside directors who are chosen from within the company, and outside directors, selected externally and held independent of WOOJUNG. The board's role is to monitor WOOJUNG BIO's management team and ensure that shareholders' interests are well served. WOOJUNG BIO's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, WOOJUNG BIO's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sang Ahn, Internal Auditor | |
| Tae Uhm, Director | |
| Byeong Cheon, Chief Executive Officer, Director | |
| Chan Hong, Director | |
| Ji Lee, Non-Executive Independent Director | |
| Jin Kim, Director | |
| Sang Byun, Non-Executive Independent Director | |
| Geon Oh, Internal Auditor | |
| Jong Ahn, Director | |
WOOJUNG Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is WOOJUNG BIO a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Pair Trading with WOOJUNG BIO
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if WOOJUNG BIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WOOJUNG BIO will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to WOOJUNG BIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace WOOJUNG BIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back WOOJUNG BIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling WOOJUNG BIO to buy it.
The correlation of WOOJUNG BIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as WOOJUNG BIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if WOOJUNG BIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for WOOJUNG BIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Other Information on Investing in WOOJUNG Stock
WOOJUNG BIO financial ratios help investors to determine whether WOOJUNG Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WOOJUNG with respect to the benefits of owning WOOJUNG BIO security.